A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s, one of the most damaging and fastest growing diseases. Pfizer’s (PFE) Lipitor is the top selling statin, bringing in $10. According to Reuters, Bristol-Myers Squibb (BMY) Pravachol and Merck (MRK) Zocor are also in this category of drugs.
Lipitor went off-patent last year, opening it to competition from generics, and the market continues to be concerned about what this will do to Pfizer’s long term earnings.
Finding a new market for the drug could work wonders.
Douglas A. McIntyre
Sponsored: Want to Retire Early? Here’s a Great First Step
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
